技术文章
Coupling Chemistry, Ligand Immobilization, and Target Capture Applications of Pre-Activated Magnetic Beads
Coupling Chemistry, Ligand Immobilization, and Target Capture Applications of Pre-Activated Magnetic Beads
The value of pre-activated magnetic beads does not lie merely in providing a magnetically separable solid support, but in integrating surface reaction sites, interfacial hydrophilicity, and downstream capture performance into a single material platform in advance. For target enrichment from proteins, nucleic acids, glycoproteins, tag-fusion proteins, exosomes, and other targets in complex biological samples, what usually determines result quality is not simply whether coupling occurs, but whether the coupling chemistry matches the ligand properties, whether the recognition site remains accessible after immobilization, and whether washing and elution conditions are compatible with the surface chemistry.
Keywords: pre-activated magnetic beads; coupling chemistry; ligand immobilization; target capture; NHS; epoxy; carboxyl; streptavidin
1. Technical positioning of pre-activated magnetic beads
1.1 Basic structure of pre-activated magnetic beads
(1) Magnetic core
Pre-activated magnetic beads are usually based on Fe3O4 or related composite magnetic cores, further coated with polymers, agarose, or silica-based materials. The magnetic core determines separation speed and magnetic responsiveness, whereas the outer coating determines surface stability and modifiability.
(2) Active surface layer
So-called pre-activation essentially means that functional groups capable of directly participating in coupling have already been introduced onto the bead surface, such as NHS, epoxy, carboxyl, amino, hydroxyl, tosyl, and streptavidin. These are not merely surface labels, but direct determinants of the subsequent ligand immobilization route.
(3) Interfacial microenvironment
Even when surface groups are the same, bead shell hydrophilicity, crosslinking density, surface smoothness, particle size, and local charge state can all alter ligand loading, nonspecific adsorption, and target diffusion efficiency. Therefore, pre-activated magnetic beads are not simply “functionalized particles,” but rather an interfacial engineering platform.
1.2 Differences between pre-activated magnetic beads and ordinary functionalized magnetic beads
(1) Shorter reaction route
Ordinary magnetic beads often require introduction of an intermediate activation layer before ligand coupling, whereas pre-activated magnetic beads can enter the ligand immobilization stage directly, making them more suitable for standardized method development and batch preparation.
(2) More concentrated method variables
When pre-activated magnetic beads are used, the main optimization targets are no longer how to prepare an active surface, but rather ligand concentration, coupling buffer, pH, blocking strategy, and capture conditions.
(3) Higher batch consistency
Pre-activated systems usually have already completed surface functionalization and baseline quality control, making them more suitable for research or applications requiring high reproducibility and strong process stability.
1.3 Core parameters in selecting pre-activated magnetic beads
(1) Surface functional group type
This determines which ligand functional groups can be linked, the coupling pH window, and reaction selectivity.
(2) Particle size and shell type
These determine specific surface area, diffusion efficiency, separation speed, and compatibility with automation.
(3) Background adsorption level
This determines purity performance in complex samples, especially in protein, exosome, and body fluid capture.
(4) Reusability
This determines whether the beads are suitable for affinity purification, repeated elution, and regeneration cycles.
2. Coupling chemistry of common pre-activated magnetic beads
2.1 NHS-activated systems
(1) Reaction basis
NHS-activated surfaces can react directly with primary amines to form stable amide bonds, making them highly suitable for rapid immobilization of amino-containing ligands such as antibodies, proteins, and peptides.
(2) Method characteristics
The reaction is fast, the operating window is clear, and this is one of the most commonly used routes for protein ligand immobilization.
(3) Main limitation
Because reactive amino groups are widely distributed across protein surfaces, coupling is usually random and ligand orientation is generally uncontrolled. If lysine residues are abundant near the recognition site, activity may decrease after immobilization.
2.2 Carboxyl-activated systems
(1) Reaction basis
Carboxyl magnetic beads are not directly coupled materials by themselves, but usually require in situ activation with systems such as EDC/NHS before forming amide bonds with ligand amino groups.
(2) Method characteristics
Their advantage lies in flexibility: activation strength and ligand addition conditions can be adjusted independently, so they are widely used in method development.
(3) Main limitation
Because the activation and coupling steps are separated, there are more experimental variables. If reaction time, pH, or activator ratios are not well controlled, reproducibility declines markedly.
2.3 Epoxy systems
(1) Reaction basis
Epoxy groups can undergo ring-opening reactions with amino, thiol, or hydroxyl groups to form stable covalent linkages.
(2) Method characteristics
They have a broad ligand compatibility range and strong linkage stability, making them suitable for systems requiring harsh washing or long-term storage.
(3) Main limitation
The reaction is usually slower and more sensitive to pH and temperature. If the ligand is unstable under mildly alkaline conditions, the usable range becomes limited.
2.4 Amino- and hydroxyl-surface systems
(1) As precursors for further derivatization
Amino magnetic beads and hydroxyl magnetic beads are not always final coupling endpoints, but are more commonly used as intermediate platforms for secondary modification and customized surface construction.
(2) Applicable scenarios
They are suitable for systems requiring self-built aldehyde groups, active esters, fluorescence-encoded layers, or nucleic acid probe interfaces.
(3) Methodological boundary
If the experimental goal is to rapidly obtain a usable capture bead, these precursor surfaces are usually less direct than NHS, epoxy, or streptavidin systems.
2.5 Tosyl systems
(1) Reaction basis
Tosyl surfaces can react covalently with amino or thiol groups in proteins and are among the classic activation modes in immunomagnetic beads and protein immobilization systems.
(2) Method characteristics
The linkage is relatively robust and suitable for immunocapture workflows requiring strong washing and longer incubation.
(3) Main limitation
Reaction conditions are usually less mild than those of NHS systems, and preservation of protein activity depends more strongly on optimization.
2.6 Streptavidin systems
(1) Binding basis
Streptavidin magnetic beads do not rely on classical covalent surface coupling, but instead use high-affinity biotin-streptavidin binding to achieve rapid ligand assembly.
(2) Method characteristics
They are best suited for modular linkage of biotinylated antibodies, oligonucleotide probes, peptides, and proteins, allowing rapid ligand exchange and high screening efficiency.
(3) Main limitation
Their core advantage is assembly convenience rather than true covalent anchoring. If free biotin is present in the system or extreme elution conditions are used, stability boundaries require additional attention.
Table 1. Common pre-activated magnetic bead surface types and coupling characteristics
Surface Type | Main Reaction Partner | Linkage Feature | Main Advantage | Main Limitation |
NHS | Amino groups | Amide bond | Fast reaction, suitable for protein ligands | Random orientation |
Carboxyl | Amino groups after activation | Amide bond | Flexible, suitable for method development | More steps |
Epoxy | Amino, thiol, hydroxyl groups | Ring-opening covalent linkage | High stability, broad applicability | Relatively slow reaction |
Amino/Hydroxyl | Precursors for secondary modification | Depends on further derivatization | Highly versatile | Does not directly represent a final capture platform |
Tosyl | Amino, thiol groups | Stable covalent linkage | Suitable for immunocapture | More condition-sensitive |
Streptavidin | Biotinylated ligands | High-affinity assembly | Modular and rapid ligand exchange | Not a strictly covalent system |
3. Key issues in ligand immobilization
3.1 Ligand type determines the immobilization route
(1) Antibody ligands
If the goal is to construct immunocapture magnetic beads, NHS, carboxyl activation, Protein A/G adsorption platforms, and streptavidin systems can all be used. Selection should focus on antibody orientation, Fc exposure, elution mode, and whether reuse is required.
(2) Nucleic acid probe ligands
These are better suited to terminal amino-, thiol-, or biotin-modified formats, corresponding respectively to NHS/carboxyl, maleimide-type strategies, or streptavidin surfaces. For nucleic acid probe immobilization, the key is probe density and hybridization accessibility, not simply high loading.
(3) Tag-binding ligands
If the target is a Flag-, HA-, His-, GST-, MBP-, V5-, GFP-, or mCherry-tagged protein, preloaded functional ligand magnetic beads are often more stable than self-coupled systems and are more suitable for rapidly establishing capture workflows.
(4) Glycan-binding and small-molecule recognition ligands
Heparin, ConA, and Strep-Tactin are function-directed ligands suitable for specific biomolecular recognition scenarios. In these cases, the focus shifts from coupling efficiency to recognition selectivity.
3.2 Ligand orientation and effective loading
(1) Total immobilized amount does not equal effective immobilized amount
A greater amount of ligand on the bead surface does not necessarily mean stronger target capture. If the surface is overcrowded, the recognition sites face the bead surface, or steric hindrance is excessive, effective capture may actually decrease.
(2) Antibody orientation is especially critical
For antibody ligands, random amino coupling often leads to disordered Fab orientation. In contrast, Protein A, Protein G, or Protein L platforms are more favorable for maintaining exposure of the binding site.
(3) Tag-specific ligands are often more stable
For fixed tag systems such as Flag, HA, and V5, direct use of preformed nanobody magnetic beads usually reduces uncertainty introduced by self-coupling.
3.3 Blocking and background control
(1) Blocking of unreacted sites
If residual active surface sites are not blocked, contaminating proteins, nucleic acids, or vesicular components in the sample may continue to adsorb or react, thereby increasing background.
(2) Nonspecific adsorption in complex samples
Plasma, serum, tissue lysates, and cell supernatants greatly amplify surface background problems. Therefore, hydrophilic shells, smooth surfaces, and moderately crosslinked structures are often more important than magnetic responsiveness alone.
4. Major application scenarios in target capture
4.1 Capture of proteins and complexes
(1) Immunoprecipitation and co-immunoprecipitation
Protein A, Protein G, Protein A/G, and related IP kits are suitable for antibody-mediated protein capture and complex enrichment, representing the most typical target-capture scenario for magnetic beads.
(2) Tagged protein purification
His, GST, Strep, Flag, HA, V5, GFP, and mCherry tag systems are suitable for rapid establishment of highly specific capture workflows. Their core strengths are clear selectivity and relatively controllable background.
(3) Enrichment of nucleic acid-binding proteins and glycoproteins
Heparin magnetic beads can be used for enrichment of heparin-binding proteins or nucleic acid-binding proteins, whereas ConA magnetic beads are suitable for glycoprotein and glycosylated-molecule recognition.
4.2 Capture of exosomes and particulate targets
(1) Magnetic bead-based exosome enrichment
Affinity magnetic bead exosome extraction kits and magnetic bead-based exosome extraction systems indicate that magnetic bead platforms are no longer limited to molecular capture, but can also be extended to nanoscale vesicles and complex particle enrichment.
(2) Application characteristics
Such systems are more sensitive to surface background, washing strength, and sample adhesiveness, and therefore depend more on stable surface engineering than on coupling efficiency alone.
4.3 Capture of nucleic acid-related targets
(1) Streptavidin systems
If the probe is already biotinylated, streptavidin magnetic beads are suitable for rapidly constructing nucleic acid capture systems.
(2) Functional nucleic acid magnetic beads
Products such as DNA methylation magnetic beads indicate that magnetic bead platforms can also be preloaded with specific nucleic acid-recognition functions for selective nucleic acid enrichment, rather than serving only as generic extraction materials.
Table 2. Correspondence between ligand immobilization and capture applications
Ligand or Platform Type | Representative Bead Type | Main Target | Key Application Focus |
Antibody adsorption platform | Protein A/G, Protein L | Proteins, complexes, cell surface molecules | Antibody orientation, background control |
Covalent immobilization platform | NHS, carboxyl, epoxy, tosyl | Antibodies, proteins, nucleic acid probes | Coupling efficiency, retention of activity |
Tag-specific magnetic beads | His, GST, Flag, HA, V5, GFP, etc. | Tag-fusion proteins | High specificity, rapid workflow |
Functional ligand magnetic beads | Heparin, ConA, Strep-Tactin | Nucleic acid-binding proteins, glycoproteins, Strep-tag proteins | Recognition selectivity |
Streptavidin platform | Streptavidin magnetic beads | Biotinylated antibodies, nucleic acids, proteins | Modular assembly |
Application-oriented magnetic bead kits | IP, exosome, methylated DNA systems | Specific samples or targets | Standardized workflow |
5. Result evaluation and method optimization
5.1 Coupling completion should not be the only criterion
(1) Activity after immobilization should be evaluated
Especially for antibodies, enzymes, and nucleic acid probes, the critical point is whether the ligand retains recognizability, catalytic activity, or hybridization capacity after coupling.
(2) Capture purity and recovery should be evaluated
High recovery with high background, or high purity with low recovery, cannot both be directly regarded as good platforms.
(3) Stability in complex samples should be evaluated
A system that performs well in simple buffer does not necessarily withstand the high-background environment of serum, lysate, or supernatant.
5.2 Typical optimization directions
(1) Ligand concentration optimization
Avoid insufficient loading that reduces capture, but also avoid excessive loading that causes surface crowding and steric hindrance.
(2) Coupling time optimization
If too short, immobilization may be insufficient; if too long, side reactions and ligand inactivation may increase.
(3) Washing condition optimization
A balance must be achieved between background removal and retention of true target molecules.
6. Product table related to pre-activated magnetic beads, ligand immobilization, and target capture
Product Type | Catalog No. | Name | Grade and Purity | Suitable Research Use/Application |
Pre-activated surface magnetic beads | NHS activated agarose magnetic beads | BioReagent, 10%（v/v） | Suitable for rapid covalent immobilization of amino-containing ligands, including antibodies, proteins, and peptides | |
Pre-activated surface magnetic beads | UltraBio™ NHS Magnetic Beads (1μm) | BioReagent, 10 mg/mL | Suitable for constructing micron-scale NHS-activated surfaces and for small-volume coupling and target-capture optimization | |
Pre-activated surface magnetic beads | UltraBio™ Epoxy Magnetic Agarose Beads | BioReagent, 10%（v/v） | Suitable for epoxy-based immobilization chemistry and stable linkage of proteins, polysaccharides, and certain nucleic acid probes | |
Pre-activated surface magnetic beads | UltraBio™ Epoxy Magnetic Beads (1μm) | BioReagent, 10 mg/mL | Suitable for micron-scale epoxy surface coupling systems requiring relatively high surface area and stable linkage | |
Pre-activated surface magnetic beads | UltraBio™ Carboxyl Magnetic Agarose Beads | BioReagent, 10%（v/v） | Suitable for amino-ligand immobilization after EDC/NHS activation and serves as a common base surface for method development | |
Pre-activated surface magnetic beads | UltraBio™ Carboxyl Magnetic Beads (1μm) | BioReagent, 10 mg/mL | Suitable for micron-scale carboxyl surface construction for coupling antibodies, proteins, and oligonucleotide probes | |
Pre-activated surface magnetic beads | Carboxyl Magnetic Beads | BioReagent, for chemiluminescence, 10mg/mL | Suitable for carboxyl coupling and construction of ligand immobilization platforms for chemiluminescent detection systems | |
Pre-activated surface magnetic beads | Carboxyl Magnetic Particles | — | Suitable for routine carboxyl surface coupling and can serve as a general ligand immobilization carrier | |
Pre-activated surface magnetic beads | Carboxyl Magnetic Particles, Cross-linked | — | Suitable for carboxyl bead systems requiring higher structural stability, supporting repeated washing and complex sample processing | |
Pre-activated surface magnetic beads | Carboxyl Magnetic Particles, Smooth Surface | — | Suitable for ligand immobilization experiments emphasizing surface uniformity and background adsorption control | |
Pre-activated surface magnetic beads | UltraBio™ Amine Magnetic Beads (1μm) | BioReagent, 10 mg/mL | Suitable for further derivatization to construct customized surfaces, or for aldehyde/active ester-based reaction systems | |
Pre-activated surface magnetic beads | Amine Magnetic Beads | BioReagent, for chemiluminescence | Suitable for amino-surface derivatization and carrier construction for luminescent detection platforms | |
Pre-activated surface magnetic beads | Amino Magnetic Particles | — | Suitable for general amino-surface modification and subsequent introduction of functional groups | |
Pre-activated surface magnetic beads | Amino Silica Magnetic Particles | — | Suitable for silica-based amino surfaces, particularly for subsequent coupling of nucleic acid probes or protein ligands | |
Pre-activated surface magnetic beads | Hydoxyl Magnetic Beads | DNase, RNase free, BioReagent, for DNA and RNA applications, 50mg/mL | Suitable as a hydrophilic base surface or for further chemical modification, and also for nucleic acid-related platform development | |
Pre-activated surface magnetic beads | Tosyl Magnetic Beads | BioReagent, for chemiluminescence, 10mg/mL | Suitable for tosyl-activated coupling and stable immobilization of antibodies and protein ligands | |
Special functional surface magnetic beads | Fluorescent Color Amino Magnetic Particles | — | Suitable for amino-surface ligand immobilization with visual encoding and for development of multiplex capture platforms | |
Special functional surface magnetic beads | Fluorescent Color Carboxyl Magnetic Particles | — | Suitable for capture systems combining carboxyl coupling with fluorescence encoding | |
Special functional surface magnetic beads | Fluorescent Color Carboxyl Magnetic Particles, High Iron | — | Suitable for carboxyl coupling platforms requiring both stronger magnetic response and fluorescence encoding | |
Modular ligand assembly platform | UltraBio™ Streptavidin Magnetic Beads | — | Suitable for rapid assembly-type immobilization of biotinylated antibodies, nucleic acid probes, and proteins | |
Modular ligand assembly platform | UltraBio™ Streptavidin Magnetic Beads (1μm) | BioReagent, 10 mg/mL; particle size: 1μm | Suitable for constructing micron-scale biotin-streptavidin systems for diagnostics and capture platform development | |
Modular ligand assembly platform | Streptavidin Magnetic Beads | BioReagent, for chemiluminescence, 10mg/mL | Suitable for biotinylated ligand assembly and target capture in luminescent detection systems | |
General affinity magnetic beads | Protein A Magnetic Beads | BioReagent, for IP, for CoIP, 10mg/mL; 200nm | Suitable for antibody capture and immunoenrichment systems, particularly for antibody-mediated target capture platforms | |
General affinity magnetic beads | Protein G Magnetic Beads | BioReagent, for IP, for CoIP, 10 mg/mL; 200nm | Suitable for immobilization of different IgG subclasses and subsequent target pull-down | |
General affinity magnetic beads | Protein A/G Magnetic Beads | BioReagent, for IP, for CoIP, 10 mg/mL, 200nm | Suitable for broader antibody source coverage and a common choice for general immunocapture platforms | |
General affinity magnetic beads | UltraBio™ Protein A/G Magrose Beads | BioReagent, 20% v/v | Suitable for antibody immobilization and target capture in complex samples | |
General affinity magnetic beads | UltraBio™ Protein G Plus Magnetic Beads | — | Suitable for extended applications of antibody adsorption and target capture in Protein G systems | |
General affinity magnetic beads | UltraBio™ Protein G Magnetic Agarose Beads | BioReagent, 10% v/v | Suitable for Protein G-directed antibody adsorption and immunoenrichment | |
General affinity magnetic beads | UltraBio™ Protein L Magnetic Agarose Beads | BioReagent, 20% v/v; particle size: 10-37 μm | Suitable for selected light-chain-dependent antibody systems and capture of specific antibody subtypes | |
General affinity magnetic beads | UltraBio™ Alkali-Tolerant Protein A Magnetic Agarose Beads | BioReagent | Suitable for antibody capture systems requiring harsher washing and regeneration conditions | |
General affinity magnetic beads | ChIP-Grade Protein A/G Magnetic Agarose Beads | BioReagent, ready-to-use, for IP | Suitable for antibody enrichment and immunocapture in high-background samples, supporting both ChIP and IP applications | |
Application-oriented capture platform | Immunoprecipitation Kit (Protein A/G Magnetic Beads) | BioReagent, for IP, ready-to-use | Suitable for capture of antibody-target complexes using Protein A/G magnetic beads | |
Application-oriented capture platform | Immunoprecipitation Kit (Protein A Magnetic Beads) | BioReagent, for IP, ready-to-use | Suitable for Protein A-based antibody-dependent target enrichment | |
Application-oriented capture platform | Immunoprecipitation Kit (Protein G Magnetic Beads) | BioReagent, for IP, ready-to-use | Suitable for antibody capture and target pull-down under Protein G conditions | |
Functional ligand magnetic beads | UltraBio™ Strep Tactin Magnetic Agarose Beads | BioReagent, 20% v/v; particle size: 10-37 μm | Suitable for specific capture and purification of Strep-tag proteins | |
Functional ligand magnetic beads | UltraBio™ Heparin Magnetic Agarose Beads | BioReagent, 20% v/v; particle size: 10-37 μm | Suitable for capture of heparin-binding proteins, nucleic acid-binding proteins, and related complexes | |
Functional ligand magnetic beads | UltraBio™ Concanavalin A Magnetic Beads (1μm) | BioReagent, 10 mg/mL; particle size:1μm | Suitable for recognition and enrichment of glycoproteins, glycosylated molecules, and certain cell-surface structures | |
Functional ligand magnetic beads | UltraBio™ GST Magnetic Agarose Beads | BioReagent, 20% v/v; particle size: 30-100 μm | Suitable for affinity capture and purification of GST-tagged proteins | |
Functional ligand magnetic beads | UltraBio™ IDA-Ni Magnetic Agarose Beads | BioReagent, 20% v/v; particle size: 30-100 μm | Suitable for capture of His-tagged proteins and represents a typical metal-chelate affinity bead system | |
Functional ligand magnetic beads | UltraBio™ NTA-Ni Magnetic Agarose Beads for His-Tag Protein Purification | BioReagent, 10% v/v | Suitable for highly specific capture and purification of His-tagged proteins | |
Functional ligand magnetic beads | UltraBio™ TED-Ni Magnetic Agarose Beads | 见COA | Suitable for His-tagged protein capture and comparison among different Ni-chelating ligand systems | |
Functional ligand magnetic beads | UltraBio™ Anti-GST Magnetic Beads | — | Suitable for direct immunocapture of GST-tagged proteins | |
Functional ligand magnetic beads | UltraBio™ Anti-MBP Magnetic Beads | — | Suitable for capture and purification of MBP-tagged proteins | |
Functional ligand magnetic beads | UltraBio™ Anti-V5 Magnetic Beads | — | Suitable for capture of V5-tagged proteins | |
Functional ligand magnetic beads | Anti-Flag Nanobody Magnetic Beads | BioReagent, Magnetic Bead Content: ≥10 mg/mL; Bead Diameter: 2 μm | Suitable for highly specific capture of Flag-tagged proteins and represents nanobody-immobilized magnetic beads | |
Functional ligand magnetic beads | Anti-GFP Nanobody Magnetic Beads | BioReagent, Magnetic Bead Content: ≥10% (V/V); Bead Diameter: 10-30 μm | Suitable for capture of GFP fusion proteins or GFP-labeled complexes | |
Functional ligand magnetic beads | Anti-HA Nanobody Magnetic Beads | BioReagent, Magnetic Bead Content: ≥10 mg/mL; Bead Diameter: 2 μm | Suitable for highly specific enrichment of HA-tagged proteins | |
Functional ligand magnetic beads | Anti-V5 Nanobody Magnetic Beads | BioReagent, Magnetic Bead Content: ≥10 mg/mL; Bead Diameter: 2 μm | Suitable for capture and pull-down of V5-tagged proteins | |
Functional ligand magnetic beads | Anti-mCherry Nanobody Magnetic Beads | BioReagent, Magnetic Bead Content: ≥10% (V/V) | Suitable for capture of mCherry fusion proteins and red fluorescently labeled targets | |
Functional ligand magnetic beads / application platform | DNA Methylation Magnetic Beads | BioReagent, for DNA and RNA applications, DNase, RNase free, 50 mg/mL; 50-100nm | Suitable for selective recognition and capture of methylated DNA and represents a functionalized magnetic bead application in nucleic acid target enrichment | |
Application-oriented capture platform | Flag-tag Protein IP Assay Kit (Nanobody Magnetic Beads Method) | BioReagent, ready-to-use, for IP | Suitable for direct capture and complex enrichment of Flag-tagged targets | |
Application-oriented capture platform | GFP-tag IP/Co-IP (Nanobody Magnetic Beads) | BioReagent, for IP | Suitable for direct capture of GFP-tagged proteins and related complexes | |
Application-oriented capture platform | His-tag IP/Co-IP Kit（Magarose Beads） | BioReagent, for IP, ready-to-use | Suitable for enrichment and pull-down of His-tagged targets | |
Application-oriented capture platform | V5-tag IP/Co-IP Kit (Nanobody Magnetic Beads) | BioReagent, for IP, ready-to-use | Suitable for direct immunocapture of V5-tagged proteins | |
Application-oriented capture platform | Plasma And Serum Exosome Isolation Kit (Affinity Magnetic Bead Method) | BioReagent, sterile | Suitable for specific exosome capture using affinity magnetic beads and serves as an application example of target capture | |
Application-oriented capture platform | Exosome Isolation Kit (Magnetic Particles) | BioReagent, sterile | Suitable for magnetic bead-based exosome enrichment and serves as an application example of nanovesicle capture | |
Control / application auxiliary magnetic beads | UltraBio™ Mouse IgG Magnetic Beads | — | Suitable as negative controls and for background assessment in immunocapture systems | |
Control / application auxiliary magnetic beads | UltraBio™ Rabbit IgG Magnetic Beads | — | Suitable for negative controls and nonspecific adsorption assessment in rabbit-antibody systems |
The true value of pre-activated magnetic beads lies in linking surface chemistry, ligand immobilization, and target capture performance into one complete system. Selection of such materials should not be based only on the name of the functional group, but should instead be judged comprehensively in combination with ligand properties, sample background, capture target, and downstream detection mode. In most applications, an appropriate surface type, an appropriate ligand loading strategy, and appropriate washing and elution conditions are usually more decisive than merely increasing bead reactivity.
For more related articles, please see below:
危险品化学品经营许可证（带存储）